Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
Maastricht University Medical Center
Maastricht University Medical Center
British Columbia Cancer Agency
Medical College of Wisconsin
University Medical Center Groningen
University of California, San Francisco
University Hospital, Ghent
Centre Georges Francois Leclerc
Centre Leon Berard
Jules Bordet Institute